Report cover image

Global Premenstrual Dysphoric Disorder (PMDD) Market Growth (Status and Outlook) 2025-2031

Published Sep 05, 2025
Length 90 Pages
SKU # LPI20370067

Description

According to this study, the global Premenstrual Dysphoric Disorder (PMDD) market size will reach US$ million by 2031.

Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.

United States market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Premenstrual Dysphoric Disorder (PMDD) players cover Teva, Eli Liliy, Pfizer, Bayer, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Premenstrual Dysphoric Disorder (PMDD) Industry Forecast” looks at past sales and reviews total world Premenstrual Dysphoric Disorder (PMDD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Premenstrual Dysphoric Disorder (PMDD) sales for 2025 through 2031. With Premenstrual Dysphoric Disorder (PMDD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Premenstrual Dysphoric Disorder (PMDD) industry.

This Insight Report provides a comprehensive analysis of the global Premenstrual Dysphoric Disorder (PMDD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Premenstrual Dysphoric Disorder (PMDD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Premenstrual Dysphoric Disorder (PMDD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Premenstrual Dysphoric Disorder (PMDD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Premenstrual Dysphoric Disorder (PMDD).

This report presents a comprehensive overview, market shares, and growth opportunities of Premenstrual Dysphoric Disorder (PMDD) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Table Product
Inject Product
Others

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Eli Liliy
Pfizer
Bayer
GSK
Apotex
Bristol Laboratories
Mylan
Allergan

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

90 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Premenstrual Dysphoric Disorder (PMDD) Market Size by Player
4 Premenstrual Dysphoric Disorder (PMDD) by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Premenstrual Dysphoric Disorder (PMDD) Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.